Selexipag | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Selexipag
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Selexipag

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 10 USDMF, 4 EU WC, 1 KDMF, 8 NDC API, 15 Listed Suppliers, $ API Reference Price

24 API Suppliers
10 USDMF
4 EU WC
1 KDMF
8 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 39 FDA Orange Book, 18 Europe, 8 Canada, 20 Australia, 8 Listed Dossiers

93 FDF Dossiers
39 FDA Orange Book
18 Europe
8 Canada
20 Australia
8 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 16 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 10 Corel Pharma Chem, 1 Finar, 5 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Novo Excipients, 3 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 37 Fillers, Diluents & Binders, 16 Controlled & Modified Release, 15 Taste Masking, 15 Direct Compression, 15 Chewable & Orodispersible Aids, 12 Disintegrants & Superdisintegrants, 9 Film Formers & Plasticizers, 8 Co-Processed Excipients, 8 Lubricants & Glidants, 6 Granulation, 5 Empty Capsules, 5 Coloring Agents, 5 Thickeners and Stabilizers, 5 Parenteral, 4 Vegetarian Capsules, 4 Solubilizers, 3 API Stability Enhancers, 3 Emulsifying Agents, 3 Topical, 1 Rheology Modifiers

42 Coating Systems & Additives
37 Fillers, Diluents & Binders
16 Controlled & Modified Release
15 Taste Masking
15 Direct Compression
15 Chewable & Orodispersible Aids
12 Disintegrants & Superdisintegrants
9 Film Formers & Plasticizers
8 Co-Processed Excipients
8 Lubricants & Glidants
6 Granulation
5 Empty Capsules
5 Coloring Agents
5 Thickeners and Stabilizers
5 Parenteral
4 Vegetarian Capsules
4 Solubilizers
3 API Stability Enhancers
3 Emulsifying Agents
3 Topical
1 Rheology Modifiers

DIGITAL CONTENT

24 NEWS #PharmaBuzz

24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 18 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
18 Finished Drug Prices
8 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

4 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

52 US Patents, 8 Health Canada Patents

52 US Patents
8 Health Canada Patents

$ API Ref.Price (USD/KG) : 203,962 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

8 All

01 8Blake Cassels & Graydon LLP

filter Patent Reset all filters

8 All

01 82445344

filter Product Reset all filters

8 All

01 8SELEXIPAG

filter Dosage Reset all filters

8 All

01 8TABLET

filter Exp Date Reset all filters

8 All

01 82022-04-25

Product Main Page

01

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 200 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 400 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 600 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 800 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1000 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1200 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1400 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Blake Cassels & Graydon LLP

Selexipag

PharmScience R&D

Not Confirmed

Blake Cassels & Graydon LLP

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1600 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!